DOI: https://doi.org/10.14710/dmj.v13i5.43109

The Art of Anti-Snake Venom Administration in Snakebite Grade III Following Viper Snakebite in Developing Country: A Case Report

*Hapsari Kinanti orcid scopus  -  Faculty of Medicine, Airlangga University, Indonesia
Agung Kusumanegara  -  Department of Surgery, Ibnu Sina General Hospital, Gresik, Indonesia, Indonesia

Citation Format:
Abstract

Snakebite remains a prior Neglected Tropical Disease in the World, especially in South-East Asia. There were many diversities in the management of snake bites based on the different levels of clinician experience. Anti-snake venom remains the mainstay treatment in venomous snakebites, meanwhile, the distribution of anti-snake venom is very sparse. Snakebite is time-limited and could be a life-threatening event. This case report described a delayed anti-snake venom administration in snakebite grade III following a viper snake bite. Tight observation including clinical manifestation and laboratory tests is the foremost thing to do in managing snakebite, due to its unpredictable clinical manifestation. Anti-snake venom dosage must be decided based on the progress of clinical manifestation and laboratory results. 

Fulltext View|Download
Keywords: Antivenom; Case report; Hematotoxin; Snakebite; Viper snake

Article Metrics:

Article Info
Section: Case Report
Language : EN
Recent articles
Relationship Between Fasting Blood Glucose Levels and Lipid Profiles in Type 2 Diabetes Mellitus Patients with Hypertension Oral and Perioral Manifestations in Monkeypox Patients: A Systematic Review of Case Reports and Case Series Factors Related to Duration and Interaction of Doctor-Patient Communication at Diponegoro National Hospital Scurvy with Musculoskeletal Pain in Indonesian Pediatric Patient: A Case Report The Art of Anti-Snake Venom Administration in Snakebite Grade III Following Viper Snakebite in Developing Country: A Case Report Identifying Acute Ischemic Stroke with Hemichorea as A Clinical Manifestation: A Case Report More recent articles
  1. Noutsos T, Currie BJ, Wijewickrama ES, Isbister GK. Snakebite Associated Thrombotic Microangiopathy and Recommendations for Clinical Practice. Toxins (Basel). 2022;14(1):1–18. https://doi.org/10.3390/toxins14010057
  2. Russell JJ, Schoenbrunner A, Janis JE. Snake Bite Management: A Scoping Review of the Literature. Plast Reconstr Surg - Glob Open. 2021;1–12. https://doi.org/10.1097/GOX.0000000000003506
  3. Ralph R, Faiz MA, Sharma SK, Ribeiro I, Chappuis F. Managing snakebite. BMJ. 2022;376(fig 1):1–10. https://doi.org/10.1136/bmj-2020-057926
  4. Adiwinata R, Nelwan EJ. Snakebite in Indonesia. Acta Med Indones. 2015;47(4):358–65
  5. Patikorn C, Ismail AK, Abidin SAZ, Blanco FB, Blessmann J, Choumlivong K, et al. Situation of snakebite, antivenom market and access to antivenoms in ASEAN countries. BMJ Glob Heal. 2022;7(3):1–11. https://doi.org/10.1136/bmjgh-2021-007639
  6. Ministry of Health I. Standart Tretment Guidelines: Management of Snakebite. Ministry of Health & Family Welfare India. 2016
  7. Chaudhary MK. A Review on Snake Bite and Its managements. Pharmacologyonline. 2020;3(February):319–26
  8. WHO. Guideline for the Management of snakebites. In New Delhi: WHO Regional Office for South-East Asia; 2016
  9. Knudsen C, Jürgensen JA, Føns S, Haack AM, Friis RUW, Dam SH, et al. Snakebite Envenoming Diagnosis and Diagnostics. Front Immunol. 2021;12(April):9–12. https://doi.org/10.3389/fimmu.2021.661457
  10. Feitosa EL, Sampaio VS, Salinas JL, Queiroz AM, Da Silva IM, Gomes AA, et al. Older age and time to medical assistance are associated with severity and mortality of snakebites in the Brazilian Amazon: A case-control study. PLoS One [Internet]. 2015;10(7):1–15. Available from: http://dx.doi.org/10.1371/journal.pone.0132237 doi: 10.1371/journal.pone.0132237
  11. M. Motawei S. A snake bite case: The value of timely diagnosis and treatment. Clin Case Stud Reports. 2019;2(4):1–4. https://doi.org/10.15761/ccsr.1000131
  12. Berling I, Isbister GK. Hematologic effects and complications of snake envenoming. Transfus Med Rev [Internet]. 2015;29(2):82–9. Available from: http://dx.doi.org/10.1016/j.tmrv.2014.09.005 doi: 10.1016/j.tmrv.2014.09.005
  13. Maduwage K, Isbister GK. Current Treatment for Venom-Induced Consumption Coagulopathy Resulting from Snakebite. PLoS Negl Trop Dis. 2014;8(10). https://doi.org/10.1371/journal.pntd.0003220
  14. Kang S, Moon J, Chun B. Does the traditional snakebite severity score correctly classify envenomated patients? Clin Exp Emerg Med. 2016;3(1):34–40. https://doi.org/10.15441/ceem.16.123
  15. Benjamin JM, Hall MAJA, Collazo M, Grisham CPTJ, Jarema D, Dye SSGC, et al. CLINICAL PRACTICE GUIDELINE ( JTS CPG ) Global Snake Envenomation Management ( CPG ID : 81 ). Res Gates [Internet]. 2020;(September). Available from: https://www.researchgate.net/publication/344026463_Global_Snake_Envenomation_Management_CPG_ID_81/link/5f4e71ae299bf13a3193e555/download
  16. Ministry of Health M. Guideline: Management of Snakebite. Minist Heal Malaysia. 2017;17
  17. Bhatt N, Singh A, Sharma SK. Case report: Management of pit viper envenoming without antivenom: A case series. Am J Trop Med Hyg. 2020;102(6):1440–2. https://doi.org/10.4269/ajtmh.20-0035

Last update:

No citation recorded.

Last update:

No citation recorded.